Have they figured out a way to “normalize” the recent rise in cancer rates? From el gato malo at boriquagato.substack.com:
and upticks in normalization based gaslighting
a lot of people are focusing on this article today in the WSJ:
obviously, this has been quite a hot topic of late.
and clearly this has not been lost on big pharma who has been notably acquisitive in the space. pfizer was buying last year. merck just did.
the biden administration has been all over this.
many seem to be presuming this WSJ piece indicates a sort of mainstreaming of the idea that we’re seeing a big cancer surge post covid/covid vaccine.
alas, i do not think this is so.
the WSJ piece does not even include the covid era. its analysis ends in 2019.
Cancer is hitting more young people in the U.S. and around the globe, baffling doctors. Diagnosis rates in the U.S. rose in 2019 to 107.8 cases per 100,000 people under 50, up 12.8% from 95.6 in 2000, federal data show. A study in BMJ Oncology last year reported a sharp global rise in cancers in people under 50, with the highest rates in North America, Australia and Western Europe.
the study is “Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019” and can be accessed through the link above.
the big jump in colorectal diagnosis seems to pop. note that these are cases, not deaths, and so it’s very possible screening rates are having a big effect here. this is not a rise in other groups. my base guess here is it’s just a big uptick in screening younger people. (why does no one ever control for sample rate?)
